Pfizer, AstraZeneca … or both? A mixed approach may hold promise against Covid

Because of unpredictable supply and some concerns about an exceedingly rare but serious clotting risk from the AstraZeneca vaccine, officials have recently issued new guidance on mixing and matching different Covid vaccines.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3pLvVFP
via IFTTT